91 related articles for article (PubMed ID: 28527995)
1. Effect of Aconitum coreanum polysaccharide and its sulphated derivative on the migration of human breast cancer MDA-MB-435s cell.
Zhang Y; Wu W; Kang L; Yu D; Liu C
Int J Biol Macromol; 2017 Oct; 103():477-483. PubMed ID: 28527995
[TBL] [Abstract][Full Text] [Related]
2. Polysaccharide sulphated derivative from Aconitum coreanum induces cell apoptosis in the human brain glioblastoma U87MG cell line via the NF-κB/Bcl-2 cell apoptotic signaling pathway.
Sun L; Wang Z; Wang H; Li J; Liang H
Oncol Rep; 2018 Mar; 39(3):1469-1474. PubMed ID: 29286151
[TBL] [Abstract][Full Text] [Related]
3. Diosgenin inhibits the migration of human breast cancer MDA-MB-231 cells by suppressing Vav2 activity.
He Z; Chen H; Li G; Zhu H; Gao Y; Zhang L; Sun J
Phytomedicine; 2014 May; 21(6):871-6. PubMed ID: 24656238
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
5. [Isolation of homogeneous polysaccharide from Poria cocos and effect of its sulfated derivatives on migration of human breast cancer MDA-MB-231 cells].
Hu K; Luo Q; Zhu XF; Sun SH; Feng GL; Liu ZY; Chen XM
Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(13):2835-2840. PubMed ID: 31359698
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of CD81 in Breast Cancer Tissue is Associated with Reduced Patient Prognosis and Increased Cell Migration and Proliferation in MDA-MB-231 and MDA-MB-435S Human Breast Cancer Cell Lines In Vitro.
Zhang N; Zuo L; Zheng H; Li G; Hu X
Med Sci Monit; 2018 Aug; 24():5739-5747. PubMed ID: 30117494
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
Ko HS; Kim JS; Cho SM; Lee HJ; Ahn KS; Kim SH; Lee EO
Bioorg Med Chem Lett; 2014 Feb; 24(4):1176-9. PubMed ID: 24440300
[TBL] [Abstract][Full Text] [Related]
8. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
9. The actin targeting compound Chondramide inhibits breast cancer metastasis via reduction of cellular contractility.
Menhofer MH; Kubisch R; Schreiner L; Zorn M; Foerster F; Mueller R; Raedler JO; Wagner E; Vollmar AM; Zahler S
PLoS One; 2014; 9(11):e112542. PubMed ID: 25391145
[TBL] [Abstract][Full Text] [Related]
10. A Aconitum coreanum polysaccharide fraction induces apoptosis of hepatocellular carcinoma (HCC) cells via pituitary tumor transforming gene 1 (PTTG1)-mediated suppression of the P13K/Akt and activation of p38 MAPK signaling pathway and displays antitumor activity in vivo.
Liang M; Liu J; Ji H; Chen M; Zhao Y; Li S; Zhang X; Li J
Tumour Biol; 2015 Sep; 36(9):7085-91. PubMed ID: 25874498
[TBL] [Abstract][Full Text] [Related]
11. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization and α-glycosidase inhibitory activity of a novel polysaccharide fraction from Aconitum coreanum.
Song J; Wu Y; Ma X; Feng L; Wang Z; Jiang G; Tong H
Carbohydr Polym; 2020 Feb; 230():115586. PubMed ID: 31887942
[TBL] [Abstract][Full Text] [Related]
13. Infection of Schistosomiasis japanicum is likely to enhance proliferation and migration of human breast cancer cells: mechanism of action of differential expression of MMP2 and MMP9.
Lin YL; Ramanujum R; He S
Asian Pac J Trop Biomed; 2011 Jan; 1(1):23-8. PubMed ID: 23569720
[TBL] [Abstract][Full Text] [Related]
14. Lack of telopeptides in fibrillar collagen I promotes the invasion of a metastatic breast tumor cell line.
Demou ZN; Awad M; McKee T; Perentes JY; Wang X; Munn LL; Jain RK; Boucher Y
Cancer Res; 2005 Jul; 65(13):5674-82. PubMed ID: 15994941
[TBL] [Abstract][Full Text] [Related]
15. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of cinnamaldehyde on invasion capacities of human breast cancer cell line MDA-MB-435S and its relation with regulating the expression of miR-27a].
Wang RP; Wang G; Sun QM; Wu J; Zou X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):964-9. PubMed ID: 25223182
[TBL] [Abstract][Full Text] [Related]
17. ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor.
Marchesin V; Montagnac G; Chavrier P
PLoS One; 2015; 10(3):e0121747. PubMed ID: 25799492
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
19. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
20. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
